companydata.dkZelandia Life Science R&D Consulting ApS: Financial statements 2022
CVR: 40206051
Zelandia Life Science R&D Consulting ApS (CVR 40206051) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -77,954 and a net result of DKK -92,207 compared with DKK 641,843 the year before. Equity amounted to DKK 172,085. The solvency ratio was 37.3%.
- Gross Profit
- -77,954 kr.
- Profit/Loss
- -92,207 kr.
- Equity
- 172,085 kr.
- Total Assets
- 461,665 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -78 t. | -92 t. | 172 t. | - |
| 2021 | - | 830 t. | 642 t. | 764 t. | - |
| 2020 | - | 307 t. | 236 t. | 322 t. | - |
| 2019 | - | 815 t. | 636 t. | 686 t. | - |
Keep an eye on Zelandia Life Science R&D Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Zelandia Life Science R&D Consulting ApS has published its annual report for 2021. Gross profit came to DKK 830,258, and the net result was DKK 641,843.
About Zelandia Life Science R&D Consulting ApS
Zelandia Life Science R&D Consulting ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kristian Tage Hansen. The company is owned by KTHolding ApS. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580.